期刊
JOURNAL OF CONTROLLED RELEASE
卷 339, 期 -, 页码 143-155出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2021.09.029
关键词
Bone regeneration; Osteogenesis; Angiogenesis; Controlled release; Growth factors; Dual delivery
资金
- Indian Council of Medical Research (ICMR), New Delhi [45/13/2020-Nan/BMS]
- Science and Engineering Research Board (SERB) [CRG/2020/000113]
- Council of Scientific & Industrial Research (CSIR) [22 (0846) /20/EMR-II]
Bone development involves various growth factors and chemicals, with dual delivery approach proving to be a more efficient strategy for bone regeneration by targeting multiple pathways and differentiation lineages simultaneously.
Bone development is a complex process involving a vast number of growth factors and chemical substances. These factors include transforming growth factor-beta, platelet-derived growth factor, insulin-like growth factor, and most importantly, the bone morphogenetic protein, which exhibits excellent therapeutic value in bone repair. However, the spatial-temporal relationship in the expression of these factors during bone formation makes the bone repair a more complicated process to address. Thus, using a single therapeutic agent to address bone formation does not seem to provide a clinically effective option. Conversely, a dual delivery approach facilitating the co-delivery of agents has proved to be a dynamic alternative since such a strategy can provide more efficient spatial-temporal action. Such delivery systems can smartly target more than one pathway or differentiation lineage and thus offer more efficient bone regeneration. This review discusses various dual delivery strategies reported in the literature employed to achieve improved bone regeneration. These include concurrent use of different therapeutic agents (including growth factors and drugs), enhancing bone formation and cell recruitment, and improving the efficiency of bone healing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据